116 related articles for article (PubMed ID: 11911987)
1. Lipofuscin and Abeta42 exhibit distinct distribution patterns in normal and Alzheimer's disease brains.
D'Andrea MR; Nagele RG; Gumula NA; Reiser PA; Polkovitch DA; Hertzog BM; Andrade-Gordon P
Neurosci Lett; 2002 Apr; 323(1):45-9. PubMed ID: 11911987
[TBL] [Abstract][Full Text] [Related]
2. Consistent immunohistochemical detection of intracellular beta-amyloid42 in pyramidal neurons of Alzheimer's disease entorhinal cortex.
D'Andrea MR; Nagele RG; Wang HY; Lee DH
Neurosci Lett; 2002 Nov; 333(3):163-6. PubMed ID: 12429373
[TBL] [Abstract][Full Text] [Related]
3. Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons.
D'Andrea MR; Nagele RG
Curr Pharm Des; 2006; 12(6):677-84. PubMed ID: 16472157
[TBL] [Abstract][Full Text] [Related]
4. Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology.
Takahashi RH; Milner TA; Li F; Nam EE; Edgar MA; Yamaguchi H; Beal MF; Xu H; Greengard P; Gouras GK
Am J Pathol; 2002 Nov; 161(5):1869-79. PubMed ID: 12414533
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of cathepsins E and D in neurons of the aged rat brain and their colocalization with lipofuscin and carboxy-terminal fragments of Alzheimer amyloid precursor protein.
Nakanishi H; Amano T; Sastradipura DF; Yoshimine Y; Tsukuba T; Tanabe K; Hirotsu I; Ohono T; Yamamoto K
J Neurochem; 1997 Feb; 68(2):739-49. PubMed ID: 9003065
[TBL] [Abstract][Full Text] [Related]
6. MAP-2 immunolabeling can distinguish diffuse from dense-core amyloid plaques in brains with Alzheimer's disease.
D'Andrea MR; Nagele RG
Biotech Histochem; 2002 Mar; 77(2):95-103. PubMed ID: 12083391
[TBL] [Abstract][Full Text] [Related]
7. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.
Ohyagi Y; Asahara H; Chui DH; Tsuruta Y; Sakae N; Miyoshi K; Yamada T; Kikuchi H; Taniwaki T; Murai H; Ikezoe K; Furuya H; Kawarabayashi T; Shoji M; Checler F; Iwaki T; Makifuchi T; Takeda K; Kira J; Tabira T
FASEB J; 2005 Feb; 19(2):255-7. PubMed ID: 15548589
[TBL] [Abstract][Full Text] [Related]
8. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels.
Schedin-Weiss S; Inoue M; Hromadkova L; Teranishi Y; Yamamoto NG; Wiehager B; Bogdanovic N; Winblad B; Sandebring-Matton A; Frykman S; Tjernberg LO
Alzheimers Res Ther; 2017 Aug; 9(1):57. PubMed ID: 28764767
[TBL] [Abstract][Full Text] [Related]
9. Myelin basic protein associates with AβPP, Aβ1-42, and amyloid plaques in cortex of Alzheimer's disease brain.
Zhan X; Jickling GC; Ander BP; Stamova B; Liu D; Kao PF; Zelin MA; Jin LW; DeCarli C; Sharp FR
J Alzheimers Dis; 2015; 44(4):1213-29. PubMed ID: 25697841
[TBL] [Abstract][Full Text] [Related]
10. Mostly separate distributions of CLAC- versus Abeta40- or thioflavin S-reactivities in senile plaques reveal two distinct subpopulations of beta-amyloid deposits.
Kowa H; Sakakura T; Matsuura Y; Wakabayashi T; Mann DM; Duff K; Tsuji S; Hashimoto T; Iwatsubo T
Am J Pathol; 2004 Jul; 165(1):273-81. PubMed ID: 15215182
[TBL] [Abstract][Full Text] [Related]
11. Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease.
Dandrea MR; Reiser PA; Gumula NA; Hertzog BM; Andrade-Gordon P
Biotech Histochem; 2001 Mar; 76(2):97-106. PubMed ID: 11440311
[TBL] [Abstract][Full Text] [Related]
12. Clusterin associates specifically with Aβ40 in Alzheimer's disease brain tissue.
Howlett DR; Hortobágyi T; Francis PT
Brain Pathol; 2013 Nov; 23(6):623-32. PubMed ID: 23521156
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody to beta peptide, recognizing amyloid deposits, neuronal cells and lipofuscin pigments in systemic organs.
Takahashi H; Utsuyama M; Kurashima C; Mori H; Hirokawa K
Acta Neuropathol; 1993; 85(2):159-66. PubMed ID: 8442408
[TBL] [Abstract][Full Text] [Related]
14. A Method for Diagnosing Alzheimer's Disease Based on Salivary Amyloid-β Protein 42 Levels.
Lee M; Guo JP; Kennedy K; McGeer EG; McGeer PL
J Alzheimers Dis; 2017; 55(3):1175-1182. PubMed ID: 27792013
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Expression of Amyloid Precursor Protein and the Ratio of Secreted Amyloid Beta 42 to Amyloid Beta 40 in SH-SY5Y Cells Stably Transfected with Wild-Type, Single-Mutant and Double-Mutant Forms of the APP Gene for the Study of Alzheimer's Disease Pathology.
Pahrudin Arrozi A; Shukri SNS; Wan Ngah WZ; Mohd Yusof YA; Ahmad Damanhuri MH; Makpol S
Appl Biochem Biotechnol; 2017 Nov; 183(3):853-866. PubMed ID: 28417423
[TBL] [Abstract][Full Text] [Related]
16. P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain.
Higgins LS; Murphy GM; Forno LS; Catalano R; Cordell B
Am J Pathol; 1996 Aug; 149(2):585-96. PubMed ID: 8701997
[TBL] [Abstract][Full Text] [Related]
17. Aβ38 in the brains of patients with sporadic and familial Alzheimer's disease and transgenic mouse models.
Reinert J; Martens H; Huettenrauch M; Kolbow T; Lannfelt L; Ingelsson M; Paetau A; Verkkoniemi-Ahola A; Bayer TA; Wirths O
J Alzheimers Dis; 2014; 39(4):871-81. PubMed ID: 24305500
[TBL] [Abstract][Full Text] [Related]
18. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry.
Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M
Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261
[TBL] [Abstract][Full Text] [Related]
19. A 31 kilodalton beta-protein immunoreactive polypeptide in neuronal lipofuscin.
Bancher C; Grundke-Iqbal I; Iqbal K; Kim KS; Wisniewski HM
Prog Clin Biol Res; 1989; 317():913-24. PubMed ID: 2690128
[TBL] [Abstract][Full Text] [Related]
20. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.
Attems J; Lintner F; Jellinger KA
Acta Neuropathol; 2004 Apr; 107(4):283-91. PubMed ID: 14986026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
